✦ LIBER ✦

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer

✍ Scribed by Pujol, Jean-Louis; Pirker, Robert; Lynch, Thomas J.; Butts, Charles A.; Rosell, Rafael; Shepherd, Frances A.; Vansteenkiste, Johan; O’Byrne, Kenneth J.; de Blas, Barbara; Heighway, Jim; von Heydebreck, Anja; Thatcher, Nick

Book ID: 121512717
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 806 KB
Volume: 83
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.11.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly docetaxel as second line chemothe

Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials

✍ Emilio Bria; Federica Cuppone; Mariangela Ciccarese; Cecilia Nisticò; Francesco 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Gefitinib vs. chemotherapy as first-line

Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials

✍ Ku, Geoffrey Y.; Haaland, Benjamin A.; de Lima Lopes, Gilberto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Gefitinib Compared with Systemic Chemoth

Gefitinib Compared with Systemic Chemotherapy as First-line Treatment for Chemotherapy-naive Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of Randomised Controlled Trials

✍ F. Wang; L.D. Wang; B. Li; Z.X. Sheng 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 835 KB

EGFR expression as a predictor of surviv

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

✍ Robert Pirker; Jose R Pereira; Joachim von Pawel; Maciej Krzakowski; Rodryg Raml 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 872 KB

Paclitaxel plus platinum or gemcitabine

Paclitaxel plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials

✍ Jiang, Jingwei; Liang, Xiaohua; Zhou, Xinli; Huang, Ruofan; Chu, Zhaohui; Zhan, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 816 KB

Phase II study of gemcitabine plus oxali

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

✍ Cappuzzo, F; Novello, S; De Marinis, F; Franciosi, V; Maur, M; Ceribelli, A; Lor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB